	Los Gastos De Explotación		Fecha
Acadia Pharmaceuticals	USD 242.88M	10.68M	2025-09
Alnylam Pharmaceuticals	USD 965.32M	84.27M	2025-12
Amgen	USD 5.9B	773M	2025-12
BioCryst Pharmaceuticals	USD -387.89M	33.7M	2025-09
Biogen	USD 1.88B	81.4M	2025-09
BioMarin Pharmaceutical	USD 807.82M	259.3M	2025-09
Cytokinetics	USD 168.69M	9.58M	2025-09
Daiichi Sankyo	JPY 468.57B	15.34B	2025-12
Enanta Pharmaceuticals	USD 126.59M	346.51M	2025-12
Esperion Therapeutics	USD 67.66M	3.6M	2024-09
Gilead Sciences	USD 4.96B	707M	2025-12
Incyte	USD 1.12B	3.53B	2025-12
Ionis Pharmaceuticals	USD 316.9M	4.69M	2025-09
Ironwood Pharmaceuticals	USD 57.33M	8.63M	2024-12
Karyopharm Therapeutics	USD 61.82M	3.24M	2024-12
Novartis	USD 9.86B	115M	2025-09
Pfizer	USD 12.91B	79.89B	2025-12
PTC Therapeutics	USD 246.3M	38.78M	2025-12
Puma Biotechnology	USD 49.26M	3.2M	2024-06
Roche Holding	CHF 21.01B	10.84B	2025-12
Sangamo BioSciences	USD 33.87M	12.89M	2024-06
Sarepta Therapeutics	USD 462.23M	33.28M	2025-09
TG Therapeutics	USD 132.34M	26.04M	2025-09
Ultragenyx Pharmaceutical	USD 321M	9.82M	2025-12
Vertex Pharmaceuticals	USD 1.93B	89.1M	2025-12
Xencor	USD 68.52M	8.26M	2025-09

PTC Therapeutics Los Gastos De Explotación - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.